Healthcare Equipment and Supplies
Company Overview of China Medical Technologies Inc.
China Medical Technologies, Inc., a medical device company, develops, manufactures, and markets immunodiagnostic and molecular diagnostic products. It uses molecular diagnostic technologies, including fluorescent in situ hybridization (FISH) and surface plasmon resonance (SPR), and enhanced chemiluminescence immunoassay (ECLIA), an immunodiagnostic technology in the development, manufacturing, and distribution of diagnostic products for the detection of various cancers, diseases, and disorders, as well as companion diagnostic tests for targeted cancer drugs. The company offers immunodiagnostic products, such as ECLIA analyzers and reagent kits for various clinical applications, including ane...
No 24 Yong Chang North Road
Beijing Economic-Technological Development Area
Founded in 1999
Key Executives for China Medical Technologies Inc.
Senior Vice President of Operations
Senior Researcher of YDME Beijing
Compensation as of Fiscal Year 2014.
China Medical Technologies Inc. Key Developments
SEC Revokes Registration Of Registered Securities Of China Medical Technologies
Nov 9 12
The registration of the registered securities of China Medical Technologies Inc., has been revoked. It failed to comply with reporting requirements of the Securities Exchange Act of 1934. Thus, it violated a crucial provision of the federal securities laws that requires public corporations to publicly disclose current, accurate financial information so that investors may make informed decisions. The revocation was ordered in an administrative proceeding before an administrative law judge.
SEC Orders Hearing On Registration Suspension Or Revocation Against China Medical Technologies
Oct 12 12
The Securities and Exchange Commission (SEC) announced the issuance of an Order Instituting Proceedings and Notice of Hearing Pursuant to Section 12(j) of the Securities Exchange Act of 1934 (Order) against China Medical Technologies, Inc. The Order alleges that the Company has failed to file an annual report for the year ended March 31, 2012 in violation of Section 13(a) of the Exchange Act and rule 13a-1 there under. A hearing will be held by an Administrative Law Judge to determine whether the allegations contained in the Order are true, to afford the Company an opportunity to establish any defenses to such allegations, and to determine whether it is necessary or appropriate for the protection of investors to suspend for a period not exceeding twelve months, or revoke the registration of each class of securities of the Company registered pursuant to Section 12 of the Securities Exchange Act of 1934. The Order requires the Administrative Law Judge to issue an initial decision no later than 120 days from the date of service of this Order, pursuant to Rule 360(a)(2) of the Commission's Rules of Practice.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries